Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2023-01-18 00:00:00 ET · period of report 2023-01-03 · accession 0001437749-23-001265 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-18 | 2023-01-03 | BLFS | GOSWAMI JOYDEEP | Dir | A - Grant | — | +10.2K | 28.8K | +55% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-03 | A | A | 10,187 | — | 28,847 | D | — | — | (F1) The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan (the "Plan") and fully vests on the first anniversary of the grant date. |